| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $638.5M | +65.5% |
| R&D Expense | $183.3M | -2.0% |
| SG&A Expense | $570.6M | +38.7% |
| Operating Income | -$166.8M | +40.6% |
| Interest Expense | -$15.9M | +26.2% |
| Pre-tax Income | -$183.7M | +36.0% |
| Income Tax | -$530K | -723.5% |
| Net Income | -$183.2M | +36.2% |
| EPS (Basic) | -$3.68 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $322.9M | +2.4% |
| Accounts Receivable | $224.5M | +58.1% |
| Inventory | $27.9M | +77.6% |
| Current Assets | $589.0M | +21.4% |
| Total Assets | $689.8M | +21.3% |
| Current Liabilities | $378.8M | +64.6% |
| Long-term Debt | $117.7M | -34.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$93.4M | +27.3% |
| Capital Expenditures | $480K | +77.8% |
| Investing Cash Flow | -$480K | -77.8% |
| Financing Cash Flow | $101.5M | +75.4% |
| Free Cash Flow | -$93.9M | +27.0% |
| +38.6% |
| EPS (Diluted) | -$3.68 | +38.6% |
| Total Liabilities |
| $601.5M |
| +17.6% |
| Stockholders' Equity | $88.3M | +54.9% |